Reconstituted AOD-9604 typically remains stable for 30-45 days when refrigerated
Although the body produces BPC-157 in small amounts, therapeutic use involves higher concentrations that are designed to stimulate healing, reduce inflammation, and improve tissue regeneration

In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
10.1196/annals.1369.020 110 SimmlerL
Compared regenerative peptides: TB-500 (Thymosin beta-4): cell migration + actin regulation
50 mg vial reconstitution math BAC water added 3.0 mL Final concentration 16.7 mg/mL Research amount 1 mg Draw volume 0.06 mL U-100 syringe units 6 units BAC water added 3.0 mL Final concentration 16.7 mg/mL Research amount 2.5 mg Draw volume 0.15 mL U-100 syringe units 15 units BAC water added 3.0 mL Final concentration 16.7 mg/mL Research amount 5 mg Draw volume 0.30 mL U-100 syringe units 30 units BAC water added 3.0 mL Final concentration 16.7 mg/mL Research amount 10 mg Draw volume 0.60 mL U-100 syringe units 60 units The values are rounded